|
May 1
|
Repligen (RGEN) Misses Q1 Earnings Estimates
|
|
May 1
|
Repligen Reports First Quarter 2024 Financial Results
|
|
Apr 23
|
Should be Confident in Repligen Corporation (RGEN)’s Long-Term Growth Potential?
|
|
Apr 17
|
Repligen to Report First Quarter 2024 Financial Results
|
|
Apr 12
|
Artisan Mid Cap Fund Trimmed Repligen Corporation (RGEN) after Share Appreciation
|
|
Mar 19
|
Repligen Appoints Maggie A. Pax to Board of Directors
|
|
Mar 18
|
Are Repligen Corporation's (NASDAQ:RGEN) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?
|
|
Mar 12
|
Repligen Corp CEO Anthony Hunt Sells 16,707 Shares
|
|
Mar 4
|
PBYI vs. RGEN: Which Stock Is the Better Value Option?
|
|
Jan 8
|
Is Repligen Corporation (NASDAQ:RGEN) Potentially Undervalued?
|
|
Dec 19
|
Repligen Corporation to Present at 42nd Annual J.P. Morgan Healthcare Conference
|
|
Dec 18
|
Here’s Why Repligen Corporation (RGEN) Rose 13% in Q3
|
|
Dec 7
|
Repligen's (NASDAQ:RGEN) investors will be pleased with their impressive 158% return over the last five years
|
|
Dec 7
|
Repligen Announces Private Convertible Transaction of $600 Million Principal Amount of 1.00% Convertible Senior Notes Due 2028 Through Exchange and New Subscription Agreements
|
|
Dec 1
|
Why Is Exact Sciences (EXAS) Up 2.5% Since Last Earnings Report?
|
|
Nov 30
|
Repligen (RGEN) Up 21.3% Since Last Earnings Report: Can It Continue?
|
|
Nov 15
|
Does Repligen Corp. (RGEN) Have a Bright Future?
|
|
Nov 14
|
UPDATE – Repligen Announces Publication of the Company’s 2022 Sustainability Report
|
|
Nov 14
|
Repligen Announces Publication of the Company’s 2022 Sustainability Report
|
|
Sep 12
|
Repligen Appoints Jason K. Garland as Chief Financial Officer
|